Tirzepatide (Mounjaro) for Weight Loss in Cheshire & Merseyside
The new weight management medication ‘Tirzepatide’ (brand name Mounjaro) has been made available to NHS patients to support weight loss.
NHS Cheshire & Merseyside is currently in the process of establishing new community-based weight management services, which are set to launch this summer.
Tirzepatide will NOT be available on prescription for weight loss from GP practices in Southport.
We anticipate that eligible patients will be contacted once the new local service is up and running, to see if they would like to be referred. Please do not contact us to make an appointment to discuss this as we are unable to refer anyone at this time.
The first group of patients eligible for Tirzepatide under the national criteria will be those who:
- Have a Body Mass Index (BMI) of 40 kg/m² or more (or 37.5 kg/m² for people from minority ethnic family backgrounds)
AND
- Have at least FOUR of the following long-term conditions:
1. Type 2 diabetes
2. Hypertension (high blood pressure)
3. Dyslipidaemia
4. Established cardiovascular disease
5. Obstructive sleep apnoea
For more information including frequently access questions, please click here.